On October 19-20, the Samuel Waxman Institute for Aging & Cancer, an affiliate of the Mark Foundation for Cancer Research, along with Jackson Laboratory, will host its 2026 Aging & Cancer Symposium.
More than 50 leading scientists and clinicians from around the world - experts in oncology, aging biology, immunology, metabolism, artificial intelligence, geriatric medicine, and translational research - will share recent findings and ideas toward advancing our understanding of the intersection between aging and cancer, one of the most urgent frontiers in medicine.
A key goal is to accelerate our ability to measure an individual's aging and cancer risk in order to redefine prevention, enable earlier interventions, and transform treatment for an aging world.
Corina Amor Vegas, M.D., Ph.D., Cold Spring Harbor Laboratory
Olga Anczukow-Camarda, Ph.D., The Jackson Laboratory
Junyue Cao, Ph.D., Rockefeller University
Vadim N. Gladyshev, Ph.D., Harvard Medical School / Brigham and Women’s Hospital
Ana P. Gomes, Ph.D., Moffitt Cancer Center
Vera Gorbunova, Ph.D., University of Rochester
Marcia Haigis, Ph.D., Harvard Medical School
Steve Horvath, Ph.D., UCLA
George Kuchel, M.D., UConn Health
Ross Levine, M.D., Memorial Sloan Kettering Cancer Center
Sheila Stewart, Ph.D., Washington University
Tuomas Tammela, M.D., Ph.D., Memorial Sloan Kettering Cancer Center
Duygu Ucar, Ph.D., The Jackson Laboratory
Nicolas Vabret, Ph.D., Icahn School of Medicine at Mount Sinai
Peter Van Galen, Ph.D., Harvard Medical School
Amit Verma, M.B.B.S., Albert Einstein College of Medicine
Junhao Wen, Ph.D., Columbia University
A. Phillip West, Ph.D., The Jackson Laboratory
Tony Wyss-Coray, Ph.D., Stanford University
Ömer Yilmaz, M.D., Ph.D., MIT / Massachusetts General Hospital
Daniel J. Zabransky, M.D., Ph.D., Johns Hopkins University
Marinka Zitnik, Ph.D., Harvard Medical School
